Research / DHR / Fundamental state Inspectable configuration
State dimensions Filing 0000313616-22-000061 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
75.29% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.39% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
28.38% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
32.17% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
9.39% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
60.95% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
25.35% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.91% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.74% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 26 states Self-history eligible
Oct 1, 2021 0/8 normalized Level 3 Dec 31, 2021 0/9 normalized Level 3 Apr 1, 2022 7/9 normalized Level 3 Jul 1, 2022 7/9 normalized Level 3 Sep 30, 2022 7/9 normalized Level 3 Dec 31, 2022 7/9 normalized Level 3 Mar 31, 2023 8/9 normalized Level 3 Jun 30, 2023 8/9 normalized Level 3 Sep 29, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 29, 2024 9/9 normalized Level 3 Jun 28, 2024 9/9 normalized Level 3 Sep 27, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 28, 2025 9/9 normalized Level 3 Jun 27, 2025 9/9 normalized Level 3 Sep 26, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 27, 2026 9/9 normalized Level 3 Jun 26, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 326.44%
Current 75.29%
Delta -251.14% Capex Intensity Decreased
Previous 4.40%
Current 4.39%
Delta -0.01% Cash Generation Increased
Previous 28.14%
Current 28.38%
Delta 0.24% Growth Increased
Previous 22.88%
Current 32.17%
Delta 9.30% Margin Increased
Previous 60.30%
Current 60.95%
Delta 0.65% Profitability Increased
Previous 18.11%
Current 25.35%
Delta 7.24% R And D Intensity Decreased
Previous 6.10%
Current 5.91%
Delta -0.19% Sbc Intensity Increased
Previous 0.72%
Current 0.74%
Delta 0.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.